ArticleCancers2020

Prospects for Clinical Development of Stat5 Inhibitor IST5-002: High Transcriptomic Specificity in Prostate Cancer and Low Toxicity In Vivo.

Cristina Maranto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.